Skip to main content

Table 2 Diabetes/obesity top 10 interventions

From: Setting priorities for knowledge translation of Cochrane reviews for health equity: Evidence for Equity

  Intervention Outcome Feasibilitya Deliverabilityb Universalityc Effect on Equityd Overall Rating (%)
1 Sulphonylureas versus insulin All-cause mortality; best-worst case scenario Range: 2–4 Total: 75 Rank: 3 Range: 2–4 Total: 75 Rank: 1 Range: 2–4 Total: 75 Rank: 5 Range: 2–4 Total: 70.83 Rank:7 76.67 Rank: 1
2 metformin vs sulphonylureas or insulin. all cause mortality Range: 2–4 Total: 87.5 Rank: 1 Range: 2–4 Total: 66.67 Rank: 5 Range: 2–4 Total: 75 Rank: 5 Range: 2–4 Total: 70.83 Rank: 7 75 Rank: 2
3 ACEi versus placebo/no treatment All cause mortality Range: 2–4 Total: 80 Rank: 2 Range: 2–4 Total: 75 Rank:1 Range: 3–4 Total: 85 Rank: 1 Range: 2–3 Total: 70 Rank: 8 71.15 Rank: 3
4 Low salt vs high salt diet Systolic BP Range: 1–3 Total: 62.5 Rank: 9 Range: 1–4 Total: 71.88 Rank: 2 Range: 2–3 Total: 59.38 Rank: 14 Range: 2–4 Total: 71.88 Rank: 5 77.5 Rank: 4
5 Exercise vs no exercise Glycated haemoglobin (%) Range: 1–3 Total: 62.5 Rank: 9 Range: 2–4 Total: 71.88 Rank: 2 Range: 2–3 Total: 71.88 Rank: 6 Range: 2–3 Total: 68.75 Rank: 9 73 Rank: 5
6 Group-based diabetes education programme versus individual routine treatment reduction in diabetes medication Range: 1–4 Total: 53.13 Rank: 15 Range: 2–4 Total: 68.75 Rank: 4 Range: 2–3 Total: 65.63 Rank: 9 Range: 2–4 Total: 81.25 Rank: 1 73 Rank: 5
7 Effects of intensive versus brief education in high risk patient samples Foot ulcer incidence (1-year follow-up) Range: 1–3 Total: 50 Rank: 16 Range: 2–4 Total: 65.63 Rank: 6 Range: 2–4 Total: 65.63 Rank: 9 Range: 2–4 Total: 78.13 Rank: 3 71 Rank: 6
8 Tight-moderate versus loose glycaemic control Pre-eclampsia Range: 0–3 Total: 46.43 Rank: 18 Range: 0–3 Total: 50 Rank: 19 Range: 0–3 Total: 53.57 Rank: 18 Range: 0–3 Total: 53.57 Rank: 18 70.31 Rank: 7
Very tight versus tight-moderate glycaemic control Maternal hospitalisation (days)
Tight versus moderate glycaemic control Maternal hypoglycaemia in first half of pregnancy
9 low glycaemic index (LGI) vs high glycaemic index large-for-gestational age Range: 2–4 Total: 68.75 Rank: 5 Range: 2–4 Total: 75 Rank: 1 Range: 2–4 Total: 78.13 Rank: 4 Range: 2–4 Total: 78.13 Rank: 3 67 Rank: 8
10 ACEi versus placebo/no treatment Systolic BP Range: 2–4 Total: 75 Rank: 3 Range: 2–4 Total: 68.75 Rank: 4 Range: 2–4 Total: 75 Rank: 5 Range: 2–3 Total: 68.75 Rank: 9 65.38 Rank: 9
  1. aIs there sufficient capacity to implement the intervention? Is it feasible to provide required training to staff? Rankings are 0 to 4. 4 = optimal (easier to implement), 0 = more difficult
  2. bConsider the level of difficulty with intervention delivery, the infrastructure required (human resources, facilities, etc.). Consider the resources available and whether the intervention is affordable. Rank 0–4, 4 = optimal (easier/fewer health system effects), 0 = more difficult/greater health system effects,
  3. cIs the intervention relevant to most countries? Rankings are 0 to 4. 4 = Optimal (more generalizable/population-based, 0 = less generalizable/specific population
  4. dDoes the distribution of the disease burden affect mainly the disadvantaged? Are the disadvantaged most likely to benefit from the intervention? Will the intervention improve equity in disease burden distribution long-term? Rankings are 0 to 4. 4 = Optimal (more generalizable/population-based, 0 = less generalizable/specific population